NEVIRA nevirapine 200 mg tablets blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

nevirapine, Quantity: 200 mg

Disponible depuis:

Sun Pharma ANZ Pty Ltd

DCI (Dénomination commune internationale):

Nevirapine

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients: colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; povidone; sodium starch glycollate type A

Mode d'administration:

Oral

Unités en paquet:

14, 60, 100

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Nevirapine in combination with antiretroviral agents is indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when Nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

Descriptif du produit:

Visual Identification: White to off-white, oval-shaped, uncoated tablets with a break line on both sides and debossed with 'RX921' on one side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2012-11-07